These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 387436)
21. [The riboxin treatment of workers in the electron vacuum tube industry suffering from dermatoses]. Shulipa IV; Turkevich IuN; Zaĭchenko AI Vestn Dermatol Venerol; 1990; (3):39-41. PubMed ID: 2142361 [TBL] [Abstract][Full Text] [Related]
22. [Triderm in the treatment of atopic dermatitis]. Kaliuzhnaia DD Voen Med Zh; 1999 Feb; 320(2):53-5. PubMed ID: 10330896 [No Abstract] [Full Text] [Related]
23. Effects of dimethyl sulfoxide on ocular inflammation. Hanna C; Fraunfelder FT; Meyer SM Ann Ophthalmol; 1977 Jan; 9(1):61-5. PubMed ID: 319730 [TBL] [Abstract][Full Text] [Related]
24. [Use of dimethyl sulfoxide in dermatology]. Seferowicz E Przegl Dermatol; 1972; 59(4):559-64. PubMed ID: 4116008 [No Abstract] [Full Text] [Related]
25. Combined steroid-antiinfective topical therapy in common dermatoses: a double-blind, multi-center study of iodochlorhydroxyquin-hydrocortisone in 277 patients. Carpenter CL; Jolly HW; McCormick GE; Schneiderman RN; Thompson JG Curr Ther Res Clin Exp; 1973 Sep; 15(9):650-9. PubMed ID: 4270829 [No Abstract] [Full Text] [Related]
26. [Experiences with josamycin therapy in dermatologic diseases]. Kiss Z Orv Hetil; 2000 May; 141(19):1015-7. PubMed ID: 10846423 [TBL] [Abstract][Full Text] [Related]
27. [Propolis therapy of certain dermatoses and burns in the far north]. Khachaturov AA; Gudkov AI Vestn Dermatol Venerol; 1969 Feb; 43(2):63-5. PubMed ID: 5376561 [No Abstract] [Full Text] [Related]
28. [Relation between the topical action of corticoids and the addition of dimethyl sulfoxide. (Importance of the concentration)]. Cerimele D; Pisanu G Minerva Dermatol; 1966 Nov; 41(11):416-20. PubMed ID: 5998900 [No Abstract] [Full Text] [Related]
29. Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases. Bornhövd EC; Burgdorf WH; Wollenberg A Curr Opin Investig Drugs; 2002 May; 3(5):708-12. PubMed ID: 12090543 [TBL] [Abstract][Full Text] [Related]
30. Clinical studies on the effectiveness of Wratizolin in the treatment of some dermatoses. Szarmach H; Wroński A; Laudańska H; Niczyporuk W Arch Immunol Ther Exp (Warsz); 1983; 31(5):655-61. PubMed ID: 6675573 [TBL] [Abstract][Full Text] [Related]
35. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases. Bornhövd E; Burgdorf WH; Wollenberg A J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925 [TBL] [Abstract][Full Text] [Related]
36. Risks of unoccluded topical steroids in clinical trials. Akers WA Arch Dermatol; 1980 Jul; 116(7):786-8. PubMed ID: 6994659 [TBL] [Abstract][Full Text] [Related]
37. [Topical tacrolimus in dermatology: what can one expect?]. Lacour JP Ann Dermatol Venereol; 2001 Dec; 128(12):1291-4. PubMed ID: 11908129 [No Abstract] [Full Text] [Related]
38. [Some results of use of steroid hormones in treatment of skin diseases]. Ashmarin IuIa; Gorgoliuk IuA; Amitan BIa; Shatova LI Vestn Dermatol Venerol; 1968 Jul; 42(7):20-5. PubMed ID: 5738069 [No Abstract] [Full Text] [Related]
39. [Remarks on the percutaneous absorption of corticoids]. Rimbaud P; Meynadier J Ann Dermatol Syphiligr (Paris); 1968; 95(3):263-7. PubMed ID: 5697207 [No Abstract] [Full Text] [Related]
40. Diagnosis and management of common dermatoses in children: atopic, seborrheic, and contact dermatitis. Fleischer AB Clin Pediatr (Phila); 2008 May; 47(4):332-46. PubMed ID: 18057146 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]